TRACON Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

TRACON Pharmaceuticals, Inc.

TRACON Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for cancer in the United States. Its clinical stage products include envafolimab (KN035), a PD-L1 single-domain antibody for the t…

Biotechnology
US, San Diego [HQ]

News

Theses · Events · Sentiments
End of TCON's Analysis
CIK: 1394319 CUSIP: 89237H209 ISIN: US89237H2094 LEI: - UEI: -
Secondary Listings
TCON has no secondary listings inside our databases.